产品介绍：
产品说明
一般描述
Lopinavir is an antiretroviral agent and a protease inhibitor indicated for the management of human immunodeficiency virus (HIV) infection. It is a key component of Kaletra, the co-formulation of lopinavir and ritonavir.
应用
Lopinavir may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations and plasma samples by chromatography techniques.
包装
Unit quantity: 170 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
注意
Please find SDS provided by EDQM here..
其他说明
Sales restrictions may apply.
基本信息
| 经验(实验)分子式 | C37H48N4O5 |
| 分子量 | 628.80 |
| NACRES | NA.24 |
产品性质
| 生物来源 | synthetic |
| 等级 | pharmaceutical primary standard |
| agency | EP |
| 包装 | pkg of 170 mg |
| manufacturer/tradename | EDQM |
| 储存条件 | protect from light |
| application(s) | pharmaceutical (small molecule) |
| 格式 | neat |
| 运输 | ambient |
| 储存温度 | 2-8℃ |
| InChI | 1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 |
| InChI key | KJHKTHWMRKYKJE-SUGCFTRWSA-N |
安全信息
| 储存分类代码 | 13 - Non Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
